Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

recurrent adult acute myeloid leukemia

Known as: Recurrent Adult AML, leukemia, relapsed adult acute myeloid, leukemia, relapsed adult acute myelogenous 
The reemergence of acute myeloid leukemia in adults after a period of remission.
National Institutes of Health

Related topics

Related topics

10 relations
Bone MarrowBone marrow stem cellHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials
Abstract The CLL-IPI is a risk-weighted prognostic model for previously untreated patients with chronic lymphocytic leukemia (CLL… Expand
2015
2015
Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid Leukemia
AbstractThe aim of this study was to investigate the role of microRNA-335 (miR-335) in determining the treatment response and… Expand
Review
2012
Review
2012
Treatment of relapsed adult acute myeloid leukemia with MLL gene arrangement after allogeneic hematopoietic stem cell transplantation:two cases and literature review
Objective:To summarize the therapy strategies for relapsed adult acute myeloid leukemia(AML) with MLL gene arrangement after… Expand
2010
2010
Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.
BACKGROUND Colorectal cancer (CRC) patients whose tumours have microsatellite instability (MSI) do not benefit from adjuvant 5… Expand
2008
2008
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients
A large proportion of adult patients with acute myeloid leukemia (AML) relapse after treatment, and some of them are resistant to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2007
2007
Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia.
BACKGROUND Bortezomib is an inhibitor of proteasome and NF-kappaB, with activity in various solid tumors and hematological… Expand
  • table I
2004
2004
High-dose Cytarabine, Etoposide and Cisplatin Salvage Chemotherapy for Relapsed Adult Acute Myeloid Leukemia.
Background : High-dose cytarabine (HDAC) and etoposide, two of the most active drugs in relapsed acute myeloid leukemia (AML… Expand
Review
2002
Review
2002
Treatment of relapsed adult acute myeloid leukemia
Main chemotherapy regimens used to treat adult patients with acute myeloid leukemia (AML) in first or further relapse were… Expand
1999
1999
Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
BACKGROUND AND OBJECTIVE High-dose cytarabine (HDAra-C), mitoxantrone and etoposide are the mainstay of several active regimens… Expand
  • table 1
  • table 2
  • table 3
1997
1997
Autokontur - An ArcTool - AML for the preparation of contours as an input source to digital elevation models
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE